President Donald Trump is once again doing what Washington too often refuses to do: pushing real solutions instead of empty talking points. On Thursday, Trump urged Congress to pass what the White House is calling the “Great Healthcare Plan,” a sweeping proposal designed to lower healthcare costs, slash prescription drug prices, and reduce insurance premiums for everyday Americans.
At the heart of the plan is Trump’s long-standing fight against outrageously high drug prices. His proposal would ensure Americans pay no more for prescription drugs than patients in other developed countries—a radical idea only in a system where pharmaceutical companies have gotten comfortable overcharging Americans for decades.
The plan would formally codify Trump’s most-favored-nation drug pricing policy, building on actions from his first term that lowered insulin costs and on recent executive orders that led to voluntary price cuts from pharmaceutical companies. According to Trump, the results speak for themselves.
“This proposal locks in the massive discount on prescription drugs that my administration is achieving through our most-favored-nations drug pricing agreement,” Trump said. “It’ll bring down drug prices 80, 90% in some cases.” Apparently, when you negotiate like a businessman instead of a bureaucrat, prices actually fall.
Existing negotiated agreements with federal health agencies would remain intact, while the plan expands access to verified, safe drugs for over-the-counter purchase. That means fewer unnecessary doctor visits, more competition, and greater transparency—three things the healthcare industry has worked very hard to avoid.
The proposal also takes aim at bloated health insurance premiums, which the administration says have been inflated by subsidies and industry middlemen. Instead of sending billions of taxpayer dollars to large insurance companies, the plan would redirect that money straight to eligible Americans, allowing them to choose the coverage that works best for them.
“The government is going to pay the money directly to you,” Trump said. “It goes to you, and then you take the money and buy your own healthcare … the big insurance companies lose and the people of our country win.” Simple, direct, and—no surprise—unpopular with the middlemen cashing the checks.
The plan would also fund cost-sharing reductions that the Congressional Budget Office estimates could save taxpayers at least $36 billion while lowering premiums on the most common Obamacare plans by more than 10%. Saving money and lowering premiums? Somehow, that was never supposed to be possible.
In another major move, the proposal would eliminate pharmacy benefit manager kickbacks, which the White House says artificially drive up insurance costs behind the scenes. To keep insurers honest, the plan introduces a new “Plain English” standard, forcing companies to clearly disclose coverage details, denial rates, profits, and overhead costs. No more hiding behind fine print and legal jargon—an alarming development for the industry.
The plan also pushes for maximum price transparency, requiring hospitals and insurers that accept Medicare or Medicaid to publicly post prices and fees. As Trump put it, “We will have maximum price transparency and costs will come down incredibly.”
Trump is now calling on Congress to act without delay, stressing that Americans need immediate relief—not more delays, studies, or excuses. And once again, the contrast is clear: a president focused on lowering costs, empowering patients, and challenging entrenched interests, versus a system that profits from confusion and high prices.
If Congress takes this seriously, the result could be exactly what Trump has promised all along—a healthcare system that works for the American people. And that’s a win worth fighting for.
